The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from CNW Group

Noveko International Announces a First Closing of its Private Placement of Units

Tuesday, January 29, 2013

Noveko International Announces a First Closing of its Private Placement of Units09:12 EST Tuesday, January 29, 2013BOUCHERVILLE, QC, Jan. 29, 2013 /CNW Telbec/ - Noveko International Inc. (TSX: EKO) (the "Corporation") is pleased to announce a first closing in connection with its private distribution of units announced on January 11, 2013. A total of 1,566,667 units were issued for an aggregate subscription amount of $188,000, of which 416,667 units ($50,000) were issued to an officer of the Corporation. Each unit comprised one (1) Class A Share and one-half warrant; each full warrant will entitle its holder to purchase one (1) Class A Share at a price of $0.20 per share, until January 28, 2015.  The securities issued pursuant to this offering are subjected to a 4-month hold period. Additional closings are expected to occur in the next few days until the maximum subscription amount of $500,000 has been raised.Profile of the CorporationThe Corporation specializes in the air filtration segment by providing its clientele with innovative and eco-energetic filtration solutions. As such, through its subsidiaries, the Corporation designs, develops, manufactures and markets air filters incorporating its patented air filtration technologies, which filters are cleanable and recyclable, and have a much longer life span than conventional air filters. These filters are used in farm buildings, in institutional, commercial, industrial and residential buildings, and in the ground and aeronautics transport industry.Through distributors, the Corporation furthermore continues to commercialize antimicrobial masks and respirators, hands sanitizers and ultrasound scanners for use in human and veterinary medicine.Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Corporation does not intend and undertakes no obligation to update or revise the forward-looking statements.SOURCE: NOVEKO INTERNATIONAL INC.For further information: André Leroux Chairman of the Board and Chief Executive Officer Tel: (450) 650-1616 / (514) 875-0606